Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Regulation of chronic inflammatory disease by Foxo3a in the bone marrow compartment

FY 2022-23

Summary
Crohn’s disease (CD) is a subset of inflammatory bowel disease (IBD) that affects 1 in 150 Canadians and requires hospitalization and surgical intervention in extreme cases. CD, unlike ulcerative colitis, may affect any part of the gastrointestinal tract which causes a patchy pattern of inflammation extending through the thickness of the bowel wall. Mutations in various genes (>30) have been identified in IBD patients that correlate with disease susceptibility. However, harboring such susceptibility mutations does not necessarily result in disease progression. Recently a genome wide association study was conducted wherein CD patients were segregated into those with a mild/stable disease and those with a progression towards aggressive disease. Mutations in four different genes (XACT, MHC II, Foxo3a and IGFBP1-3) were identified that selectively correlated with progression towards aggressive CD. We have recently developed a new mouse model of CD where we reported that Foxo3a prevents the progression of CD. While Foxo3a prevents the development of inflammatory response in the gut, our preliminary results indicate that the early signaling mechanisms responsible for the development of CD start in the bone marrow and it is in this compartment that Foxo3a appears to restrict the progression of CD. We propose to unravel the specific mechanism through which Foxo3a prevents the development of inflammatory response in the bone marrow. We propose to sequence the genome of various cell types in the bone marrow and identify specific genes and pathways that are modulated by Foxo3a. Identification of these pathways will result in the development of novel therapeutic avenues.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486586
Name
Brandt Willem J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Regulation of chronic inflammatory disease by Foxo3a in the bone marrow compartment
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cytokines; Hematopoiesis; Inflammation; Inflammatory Bowel Disease; Innate Immunity; Leukemia
Abstract
Crohn’s disease (CD) is a subset of inflammatory bowel disease (IBD) that affects 1 in 150 Canadians and requires hospitalization and surgical intervention in extreme cases. CD, unlike ulcerative colitis, may affect any part of the gastrointestinal tract which causes a patchy pattern of inflammation extending through the thickness of the bowel wall. Mutations in various genes (>30) have been identified in IBD patients that correlate with disease susceptibility. However, harboring such susceptibility mutations does not necessarily result in disease progression. Recently a genome wide association study was conducted wherein CD patients were segregated into those with a mild/stable disease and those with a progression towards aggressive disease. Mutations in four different genes (XACT, MHC II, Foxo3a and IGFBP1-3) were identified that selectively correlated with progression towards aggressive CD. We have recently developed a new mouse model of CD where we reported that Foxo3a prevents the progression of CD. While Foxo3a prevents the development of inflammatory response in the gut, our preliminary results indicate that the early signaling mechanisms responsible for the development of CD start in the bone marrow and it is in this compartment that Foxo3a appears to restrict the progression of CD. We propose to unravel the specific mechanism through which Foxo3a prevents the development of inflammatory response in the bone marrow. We propose to sequence the genome of various cell types in the bone marrow and identify specific genes and pathways that are modulated by Foxo3a. Identification of these pathways will result in the development of novel therapeutic avenues.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brandt, Willem J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~